From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Risk for Breast Cancer After Benign Breast Biopsy

Some benign histologic entities confer more risk than others.

Benign breast disease is a risk factor for breast cancer, and some benign histologic entities confer more risk than others. In this study, Mayo Clinic researchers identified 9087 women with benign findings on breast biopsy, and compared their subsequent incidence of breast cancer with the expected incidence from cancer surveillance data for the upper midwestern U.S.

During a median follow-up of 15 years, breast cancer developed in 6.3% of women with nonproliferative histology, in 9.8% of those with proliferative disease without atypia, and in 19% of those with atypical hyperplasia. Compared with risk in the reference population, risk for breast cancer in each of these three groups was significantly increased (relative risks, 1.3, 1.9, and 4.2, respectively). Increased risk persisted for 25 years after a benign biopsy. However, risk for breast cancer was not increased in a subgroup of patients with nonproliferative disease who did not have strong family histories of breast cancer.

Comment: These findings help to refine the probabilities of subsequent breast cancer among women with benign findings on breast biopsy. They confirm a progressive increase in risk, according to specific histologic characteristics.

— Allan S. Brett, MD

Published in Journal Watch General Medicine July 29, 2005

Citation(s):

Hartmann LC et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005 Jul 21; 353:229-37.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Related Content

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.